Results 131 to 140 of about 9,040 (176)

Genomic Epidemiology of Rift Valley Fever Virus Involved in the 2018 and 2022 Outbreaks in Livestock in Rwanda. [PDF]

Viruses
Nsengimana I, Juma J, Roesel K, Gasana MN, Ndayisenga F, Muvunyi CM, Hakizimana E, Hakizimana JN, Eastwood G, Chengula AA, Bett B, Kasanga CJ, Oyola SO.   +12 more
europepmc   +1 more source

Live-cell 3D-SIM of Rift Valley fever virus NSs filaments reveals a polygonal web architecture

Dunlop J, Thomason PA, Carlin LM, Davis BG, Carter SD.   +4 more
europepmc   +1 more source

Efficient Identification of Monoclonal Antibodies Against Rift Valley Fever Virus Using High-Throughput Single Lymphocyte Transcriptomics of Immunized Mice. [PDF]

Antibodies (Basel)
Rosenfeld R, Alcalay R, Yahalom-Ronen Y, Melamed S, Sarusi-Portuguez A, Noy-Porat T, Israeli O, Beth-Din A, Blecher-Gonen R, Chitlaru T, Bar-Haim E, Israely T, Zvi A, Makdasi E.   +13 more
europepmc   +1 more source

Rift Valley fever virus infection : physiopathology and pathogenesis [PDF]

Virologie, 2021
Rift Valley fever (RVF) is a major emerging arboviral disease with a complex epidemiological cycle. RVF virus (RVFV) is transmitted by mosquito vectors to ruminants, causing epizootics, and then from animals to humans, triggering epidemics. During its cycle, RVFV infects a wide range of hosts, but the associated pathogenesis has yet to be elucidated ...
Quellec, Jordan, Salinas, Sara, Simonin, Yannick, Cêtre-Sossah, Catherine   +3 more
openaire   +3 more sources

Some of the next articles are maybe not open access.

Related searches:

Rift Valley fever virus

Journal of the American Veterinary Medical Association, 2009
Vet Med Today: Zoonosis Update 883 R Valley fever virus is a mosquito-borne pathogen of livestock and humans that historically has been responsible for widespread and devastating outbreaks of severe disease throughout Africa and, more recently, the Arabian Peninsula. The virus was first isolated and RVF disease was initially characterized following the
Brian H, Bird, Thomas G, Ksiazek, Stuart T, Nichol, N James, Maclachlan   +3 more
openaire   +2 more sources

Rift Valley fever virus: Unanswered questions

Antiviral Research, 2016
This mosquito-borne pathogen of humans and animals respects no international or geographic boundaries. It is currently found in parts of Africa and the Arabian Peninsula where periodic outbreaks of severe and fatal disease occur, and threatens to spread into other geographic regions.
Brian H, Bird, Anita K, McElroy
openaire   +2 more sources

Biochemical characterization of Rift Valley fever virus

Virology, 1980
Abstract : Rift Valley fever virus (RVFV) polypeptides were shown to share similar biochemical properties with members of the family Bunyaviradae. Electrophoretic analysis of RVFV revealed one nonglycosylated and two glycosylated major proteins with molecular weights of 25,000, 56,000, and 65,000 respectively.
R M, Rice, B J, Erlick, R R, Rosato, G A, Eddy, S B, Mohanty   +4 more
openaire   +2 more sources

Rift Valley Fever Virus Vaccine

The American Journal of Tropical Medicine and Hygiene, 1963
Summary The procedure for the production of Rift Valley fever vaccine (RVF) has been described. Infectious vacuolating virus, SV 40, was present in 3 of 6 lots of inactivated RVF vaccine prepared from rhesus kidney cell cultures but was not detected in any of 5 sequential lots prepared in Cercopithecus cell cultures. Moreover, formalin-killed RVF virus
Raymond Randall, L. N. Binn, V. R. Harrison   +2 more
openaire   +1 more source

Reverse Genetics System for Rift Valley Fever Virus

2023
Rift Valley fever virus (RVFV) is an important mosquito-borne virus that can cause severe disease manifestations in humans including ocular damage, vision loss, late-onset encephalitis, and hemorrhagic fever. In ruminants, RVFV can cause high mortality rates in young animals and high rates of abortion in pregnant animals resulting in an enormous ...
Breanna, Tercero, Shinji, Makino
openaire   +2 more sources

Immunization Against Rift Valley Fever Virus

The Journal of Immunology, 1964
Summary Lyophilization of formalin-inactivated Rift Valley fever virus vaccine, prepared in African green monkey kidney cell cultures, was successfully accomplished by the addition of 2% U.S.P. human serum albumin (HSA). The choice of HSA as an additive was made because it is non-allergenic for man and is not known to contain infectious ...
Raymond Randall, L N Binn, V R Harrison
openaire   +1 more source